- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05602922
Liu-Zi-Jue Exercise Combined With Conventional Rehabilitation Treat Dysphagia in Post-stroke
A Randomised Controlled Study of Liu-Zi-Jue Exercise Combined With Conventional Rehabilitation for Dysphagia in Post-stroke
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: BEI QIU
- Phone Number: 15270855600
- Email: 1109476936@qq.com
Study Contact Backup
- Name: RUIJIE MA, Doctor
- Phone Number: 18057102851
- Email: maria7878@sina.com
Study Locations
-
-
浙江
-
Hangzhou, 浙江, China, 310000
- Recruiting
- the Third Affiliated Hospital of Zhejiang Chinese Medical University
-
Contact:
- BEI QIU
- Phone Number: 15270855600
- Email: 1109476936@qq.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1.Meeting the diagnostic criteria of stroke in traditional Chinese medicine. 2.Meeting the diagnostic criteria of ischemic stroke in Western medicine. 3.Meeting the diagnostic criteria for swallowing disorders. 4.30 ≤ age ≤ 85 years; gender not restricted. 5.Duration of illness ≤ 180 days. 6.Water test at level 3 and above. 7.Voluntary participation in the subject, no serious complications, acceptable and good compliance with Liu-Zi-Jue Exercise treatment.
8.Sign the informed consent form.
Exclusion Criteria:
- Patients with true bulbar palsy caused by brainstem encephalitis, motor neuron disease, pontine extension tumor, multiple sclerosis, myasthenia gravis, syringomyelia, etc.
- Cerebrovascular malformation, trauma, aneurysm, etc.
- Pregnant or lactating women.
- Patients with severe primary chronic diseases such as heart, liver, kidney and other organs, as well as endocrine system and hematopoietic system, severe dementia and cognitive impairment (Simple Mental State Scale Examination (MMSE): score <15 points), severe language comprehension disorder, mentally ill patients.
- Patients with various bleeding tendency diseases.
- Patients who are allergic to swallowing contrast drugs.
- Patients who do not meet the inclusion criteria, do not have poor treatment compliance as prescribed, cannot judge the efficacy or have incomplete data, which affect the judgment of efficacy and are not suitable for clinical observation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: basic treatment+ swallowing rehabilitation treatment
Swallowing function training mainly includes indirect training, direct training, and compensatory techniques, once a day for 20 minutes each time.
In addition, a low-frequency electric VitalStim swallowing therapy device (produced by Chattanooga, USA) was also used for electrical stimulation therapy.
The treatment parameters were 700ms in width, two-way square wave, 0~25mA in amplitude, and 30~80Hz in fixed frequency.
The A electrode of channel 1 is placed above the hyoid bone, and the B electrode is placed above the notch on the thyroid cartilage.
The channel 2 electrode C and electrode D of the therapeutic apparatus are arranged vertically and equidistantly according to the electrode A and electrode B. After the electrodes are placed, turn on the power.
The stimulation intensity is based on the maximum stimulation that the patient can tolerate.
1 time a day, 30min each time, a total of 4 weeks.
|
Basic treatment +Swallowing rehabilitation training
|
|
Experimental: basic treatment+ swallowing rehabilitation treatment+ Liu-Zi-Jue
On the basis of the control group, the Liu-Zi-Jue exercises were performed, including "Xu, He, Hu, Si, Chui, Xi", 6 times each time, 5 times a week, each exercise for 30 minutes, and continuous treatment for 4 weeks.
|
Combined with the actual situation of stroke patients, this Liu-Zi-Jue Exercise adopts the sitting position.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Change in Standardized Swallowing Assessment
Time Frame: Baseline, 4 weeks and 60 days
|
The scale consists of 3 parts, the first part includes the overall evaluation of the patient's consciousness, lip closure control, head and trunk control, breathing pattern, soft palate movement, posterior function, gag reflex, spontaneous cough, etc., with a total of 8-23 points; Part 2: Let the patient drink 5ml of water, repeat 3 times, observe the water flow at the corners of the mouth when drinking water, laryngeal movement during swallowing, repeated swallowing, wheezing and laryngeal function, a total of 5 to 11 points; in the second part, if 2 or more times swallowing is normal Then carry out the third part of the assessment: the patient drinks 60 ml of water, and observes the drinking and swallowing, with a total of 5 to 12 points.
The total score of this scale is 18-46 points, and the higher the score, the worse the swallowing function.
|
Baseline, 4 weeks and 60 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Video fluoroscopic swallowing study
Time Frame: Baseline and 4 weeks
|
The scale mainly includes three parts: oral stage, pharyngeal stage, and the degree of aspiration.
The oral stage is 0-2 points; the pharyngeal stage is 0-3, and the degree of aspiration is 0-4.
The total score is 9 points.
The higher the value, the better the swallowing function.
|
Baseline and 4 weeks
|
|
The volume viscosity swallow test
Time Frame: Baseline and 4 weeks
|
The volume selected during the test is a small amount (5ml), a medium amount (10ml), a large amount (20ml), and the consistency is low consistency (water sample), medium consistency (thick paste), high consistency (pudding), according to different Combination, the complete test requires a total of 9 mouthfuls to eat, observe whether the patient coughs, whether the sound quality changes, and whether the blood oxygen saturation decreases to determine the patient's swallowing safety, observe the patient's lip closure, oral cavity residue, pharyngeal residue, and divided swallowing to determine the patient's swallowing status Effectiveness to analyze the risk of swallowing and eating in patients.
|
Baseline and 4 weeks
|
|
Penetration-aspiration scale
Time Frame: Baseline and 4 weeks
|
The scale is divided into 3 categories and 8 grades according to whether the contrast agent enters the airway, the depth of entering the airway, and whether it can be discharged.
|
Baseline and 4 weeks
|
|
Water swallow test
Time Frame: Before treatment, after 4 weeks of treatment and after 60 days of treatment.
|
The patient sits, drinks 30 ml of warm water, and is divided into 5 grades according to the time required and the condition of choking.
|
Before treatment, after 4 weeks of treatment and after 60 days of treatment.
|
|
Modified Barthel Index
Time Frame: Baseline, 4 weeks and 60 days
|
The scale is scored by the patient's ability to complete specific tasks in daily life, including grooming, eating, bathing, dressing, stool control, urination control, toilet use, bed and chair transfer, walking on level ground, and going up and down stairs with 10 items.
|
Baseline, 4 weeks and 60 days
|
Collaborators and Investigators
Investigators
- Study Director: RUJIE MA, Doctor, the Third Affiliated Hospital of Zhejiang Chinese Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20220605105846789
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Basic treatment +Swallowing rehabilitation training
-
The Second Affiliated Hospital of Dalian Medical...Recruiting
-
Chimei Medical CenterRecruitingStroke | Dysphagia | Post-Stroke DysphagiaTaiwan
-
Seoul National University HospitalRecruiting
-
Zeng ChanghaoCompleted
-
Zeng ChanghaoWithdrawn
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou UniversityWithdrawn
-
MuhammadNot yet recruiting
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou UniversityTerminatedCerebral Small Vessel DiseasesChina
-
Zeng ChanghaoNot yet recruiting
-
University of Alabama at BirminghamAmerican Academy of Otolaryngology-Head and Neck Surgery FoundationCompletedHead and Neck CancerUnited States